Search results: Sage Journals

Available accessResearch articleFirst published October, 2023

Impact of Glucagon-Like Peptide 1 Receptor Agonists in Patients with Hemoglobin A1c of 9% or Greater

Victor Tran, Henry Tran, Shaban Demirel [...]

Journal of Pharmacy Practice

Available accessOtherFirst published June, 2025

Glucagon-Like Peptide 1 Receptor Agonists and the Deepening Health Equity Divide in America

Kateri J. Spinelli, Allison H. Oakes

American Journal of Health Promotion

Open accessResearch articleFirst published November, 2025

Unraveling the obesity–asthma link: A new horizon with glucagon-like peptide-1 receptor agonists in a complex intersection of metabolism and airway disease

Francesco Menzella, Marcello Cottini, Rory Chan

Journal of International Medical Research

Free accessResearch articleFirst published January, 2016

Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis

Tracey Gaspari, Melita Brdar, Huey Wen Lee [...]

Diabetes & Vascular Disease Research

Available accessReview articleFirst published June, 2026

Glucagon-like Peptide-1 Receptor Agonists and Reproductive Health: Current Evidence and Clinical Implications

Jordyn Kettner, Elizabeth Donnelly, Marina L. Maes

Journal of Pharmacy Practice

Available accessResearch articleFirst published January, 2012

Safety and tolerability of glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes

Rupa Ahluwalia, Jiten Vora

The British Journal of Diabetes & Vascular Disease

Available accessResearch articleFirst published October, 2022

Effect of Antidepressants on Glucagon-Like Peptide-1 Receptor Agonist-Related Weight Loss

Natalie Durell, Rachel Franks, Scott Coon [...]

Journal of Pharmacy Technology

Open accessMeeting reportFirst published March, 2025

The Promise of Adjunct Medications in Improving Type 1 Diabetes Outcomes: Glucagon-Like Peptide Receptor Agonists

Sujatha Seetharaman, Eda Cengiz

Journal of Diabetes Science and Technology

Available accessArticle commentaryFirst published 2026

Implications of Glucagon-Like Peptide-1 Receptor Agonists in Otolaryngology – Head and Neck Surgery: A Review

Brady J. Anderson, Douglas J. Van Daele, Alexander D. Claussen [...]

Annals of Otology,Rhinology & Laryngology

Available accessResearch articleFirst published 2026

Assessing the Impact of Glucagon-like Peptide-1 and Glucagon-like Peptide-1/glucose-dependent Insulinotropic Polypeptide Receptor Agonist Shortages on Glycemic Control: A Single Center Study

Christian Dacon, Pramodini Kale-Pradhan, Melissa Lipari

Journal of Pharmacy Practice

Available accessResearch articleFirst published October, 2023

Impact of Glucagon-Like Peptide 1 Receptor Agonists in Patients with Hemoglobin A1c of 9% or Greater

Victor Tran, Henry Tran, Shaban Demirel [...]

Journal of Pharmacy Practice

Available accessOtherFirst published June, 2025

Glucagon-Like Peptide 1 Receptor Agonists and the Deepening Health Equity Divide in America

Kateri J. Spinelli, Allison H. Oakes

American Journal of Health Promotion

Open accessResearch articleFirst published November, 2025

Unraveling the obesity–asthma link: A new horizon with glucagon-like peptide-1 receptor agonists in a complex intersection of metabolism and airway disease

Francesco Menzella, Marcello Cottini, Rory Chan

Journal of International Medical Research

Free accessResearch articleFirst published January, 2016

Molecular and cellular mechanisms of glucagon-like peptide-1 receptor agonist-mediated attenuation of cardiac fibrosis

Tracey Gaspari, Melita Brdar, Huey Wen Lee [...]

Diabetes & Vascular Disease Research

Available accessReview articleFirst published June, 2026

Glucagon-like Peptide-1 Receptor Agonists and Reproductive Health: Current Evidence and Clinical Implications

Jordyn Kettner, Elizabeth Donnelly, Marina L. Maes

Journal of Pharmacy Practice

Available accessResearch articleFirst published January, 2012

Safety and tolerability of glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes

Rupa Ahluwalia, Jiten Vora

The British Journal of Diabetes & Vascular Disease

Available accessResearch articleFirst published October, 2022

Effect of Antidepressants on Glucagon-Like Peptide-1 Receptor Agonist-Related Weight Loss

Natalie Durell, Rachel Franks, Scott Coon [...]

Journal of Pharmacy Technology

Open accessMeeting reportFirst published March, 2025

The Promise of Adjunct Medications in Improving Type 1 Diabetes Outcomes: Glucagon-Like Peptide Receptor Agonists

Sujatha Seetharaman, Eda Cengiz

Journal of Diabetes Science and Technology

Available accessArticle commentaryFirst published 2026

Implications of Glucagon-Like Peptide-1 Receptor Agonists in Otolaryngology – Head and Neck Surgery: A Review

Brady J. Anderson, Douglas J. Van Daele, Alexander D. Claussen [...]

Annals of Otology,Rhinology & Laryngology

Available accessResearch articleFirst published 2026

Assessing the Impact of Glucagon-like Peptide-1 and Glucagon-like Peptide-1/glucose-dependent Insulinotropic Polypeptide Receptor Agonist Shortages on Glycemic Control: A Single Center Study

Christian Dacon, Pramodini Kale-Pradhan, Melissa Lipari

Journal of Pharmacy Practice